SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 37 filers reported holding SIO GENE THERAPIES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $26,000 | – | 94,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,186,335 | $8,316,000 | 0.89% |
| Opaleye Management Inc. | 2,000,000 | $5,220,000 | 0.77% |
| Prosight Management, LP | 205,900 | $537,000 | 0.44% |
| Rubric Capital Management LP | 2,500,418 | $6,526,000 | 0.38% |
| Sio Capital Management, LLC | 460,248 | $1,201,000 | 0.24% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,489,000 | $14,326,000 | 0.21% |
| KNOTT DAVID M | 70,000 | $183,000 | 0.08% |
| Insight Advisors, LLC/ PA | 82,700 | $232,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 146,968 | $384,000 | 0.06% |
| Hudson Bay Capital Management LP | 1,600,000 | $4,176,000 | 0.05% |